Opus Genetics, Inc.
IRD
$4.03
-$0.03-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -44.19% | 25.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -44.19% | 25.53% | |||
| Cost of Revenue | 0.47% | 62.71% | |||
| Gross Profit | -26.77% | -97.09% | |||
| SG&A Expenses | 23.60% | -1.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.85% | 34.49% | |||
| Operating Income | -25.42% | -37.81% | |||
| Income Before Tax | -296.63% | 5.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -296.63% | 5.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -296.63% | 5.33% | |||
| EBIT | -25.42% | -37.81% | |||
| EBITDA | -25.45% | -37.86% | |||
| EPS Basic | -267.90% | 17.04% | |||
| Normalized Basic EPS | -267.99% | 17.03% | |||
| EPS Diluted | -267.90% | 17.04% | |||
| Normalized Diluted EPS | -267.99% | 17.03% | |||
| Average Basic Shares Outstanding | 7.83% | 14.08% | |||
| Average Diluted Shares Outstanding | 7.83% | 14.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||